The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The 5-HT7 receptor has been suggested as a target for treating depression since inactivation or blockade of the receptor has an antidepressant-like behavioral effect. The present study investigated possible interactions between various classes of drugs with antidepressant properties and blockade or inactivation of the 5-HT7 receptor. Immobility despair in the tail suspension test and the forced swim test was evaluated in mice lacking the 5-HT7 receptor (5-HT7−/−) and in wild-type controls (5-HT7+/+) following acute drug treatments. Citalopram, a selective serotonin reuptake inhibitor and widely used antidepressant, dose-dependently reduced immobility in the tail suspension test in both 5-HT7+/+ and 5-HT7−/− mice. Combining doses of citalopram and the 5-HT7 receptor antagonist SB-269970 that by themselves did not affect behavior, reduced immobility in 5-HT7+/+ mice in both the tail suspension test and the forced swim test. No effect was seen in 5-HT7−/− mice. Desipramine and reboxetine, two norepinephrine reuptake inhibitors, dose-dependently reduced immobility in the tail suspension test in 5-HT7+/+ mice, but had no effect in 5-HT7−/− mice. A synergistic effect between desipramine and SB-269970 was found in both behavioral tests in 5-HT7+/+ mice. Reboxetine combined with SB-269970 had effect only in the forced swim test. GBR 12909, a dopamine reuptake inhibitor, dose-dependently reduced tail suspension test immobility in both genotypes. There was no interaction between GBR 12909 and SB-269970. Aripiprazole, an antipsychotic, reduced immobility in both tests in 5-HT7+/+ mice, but not in 5-HT7−/− mice. The results show that the 5-HT7 receptor is required for the observed interaction between this receptor and antidepressants such as citalopram. The data furthermore support the hypothesis that the 5-HT7 receptor might be a suitable target for treating depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 2×
“Although long-term treatment with drugs like citalopram is required in the clinic to obtain therapeutic effect, acute single injections are sufficient when using animal models [7].”
BackgroundCryan, J. F., & Mombereau, C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001457 · Cited by 616 · cited 1×
“Behavioral models of significant value for evaluating putative antidepressants and for characterizing transgenic mice [7,8] include the forced swim test [9] and the tail suspension test [10].”
Background5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern
Hedlund, P. B., Huitron-Resendiz, S., Henriksen, S. J., & Sutcliffe, J. G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.012 · Cited by 281 · cited 8×
“Previous studies [11,12] and the present data show a strong correlation between effects seen in the tail suspension test and the forced swim test in 5-HT7 mice and by using a selective 5-HT7 receptor antagonists.”
BackgroundMethodResultSelf-citationBerman, R. M., Fava, M., Thase, M. E., Trivedi, M. H., Swanink, R., McQuade, R. D., Carson, W. H., Adson, D., Taylor, L., Hazel, J., et al. (2009) · CNS Spectrums · doi:10.1017/s1092852900020216 · Cited by 260 · cited 2×
“To extend these findings we have in the present study investigated aripiprazole, an atypical antipsychotic with high affinity for the 5HT7 receptor [36] that is approved as augmentation therapy to antidepressants [37] and that has recently has been shown to potentiate the effect of fluoxetine [38].”
BackgroundResultSánchez, C., & Meier, E. (1997) · Psychopharmacology · doi:10.1007/s002130050181 · Cited by 255 · cited 1×
“It has been shown to reduce immobility in the forced swim test [47] and the tail suspension test [48].”
BackgroundThe 5-HT7 receptor and disorders of the nervous system: an overview
Hedlund, P. B. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1626-0 · Cited by 239 · cited 2×
“These findings have led to the hypothesis that the 5-HT7 receptor might be suitable new target for the treatment of depression [16–19].”
BackgroundSelf-citationSerotonin regulates hippocampal glucocorticoid receptor expression via a 5-HT7 receptor
Laplante, P., Diorio, J., & Meaney, M. J. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00550-3 · Cited by 135
Cited by
Bang-Andersen, B., Ruhland, T., Jørgensen, M., Smith, G., Frederiksen, K., Jensen, K. G., Zhong, H., Nielsen, S. M., Hogg, S., Mørk, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101459g · Cited by 606
Mørk, A., Pehrson, A., Brennum, L. T., Nielsen, S. M., Zhong, H., Lassen, A. B., Miller, S., Westrich, L., Boyle, N. J., Sánchez, C., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189068 · Cited by 271
“5-HT7 receptor antagonists show antidepressantlike activity in the mouse forced swim and tail-suspension tests (Sarkisyan et al., 2010) and a synergistic augmentation of extracellular 5-HT levels in the rat prefrontal cortex when combined with an SSRI (Bonaventure et al., 2007).”
BackgroundBarnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., et al. (2021) · Pharmacological Reviews · doi:10.1124/pr.118.015552 · Cited by 263
Self-citationLeopoldo, M., Lacivita, E., Berardi, F., Perrone, R., & Hedlund, P. B. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.013 · Cited by 198
Self-citationWallace, A., Pehrson, A. L., Sánchez, C., & Morilak, D. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000571 · Cited by 97
“Blockade of 5-HT7 receptors has antidepressant-like effects in the mouse FST and tail suspension tests (Sarkisyan et al., 2010), and a synergistic interaction was seen between sub-effective doses of 5-HT7 receptor antagonists and SSRIs on the same tests (Bonaventure et al., 2007).”
Background
Metadata
- Authors
- Sarkisyan, G., Roberts, A. J., & Hedlund, P. B.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 209
- Issue
- 1
- Pages
- 99-108
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W1982173448
- Cited by
- 114
- References
- 9
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior. https://app.cochat.ai/papers/10.1016/j.bbr.2010.01.022
- The paper
- Sarkisyan, G., Roberts, A. J., & Hedlund, P. B. (2010). The 5-HT7 receptor as a mediator and modulator of antidepressant-like behavior. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2010.01.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.